Holen Sie sich die Stockscreener-App
1.34
4.69%
0.06
Vorhandelsmarkt:
1.34
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Evogene Announces Annual General Meeting for August 2025 - TipRanks
Citadel Advisors LLC Makes New Investment in Evogene Ltd. (NASDAQ:EVGN) - Defense World
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud - MSN
Cannabis Stocks To Keep An Eye On – June 10th - Defense World
Evogene, Google Cloud innovation to revolutionise ag-chemicals - Far Eastern Agriculture
Evogene Becomes Talk Of Retail Town As Stock Doubles On Genai Drug, Agri Discovery Model With Google Cloud - MENAFN.com
AI And Tech Stocks Climb With Major Partnerships And Innovations - Finimize
Evogene iyo Google Cloud Unveil Model ee Naqshadaynta Molecule Generative, Hormoodka Waa Cusub ee Sayniska Nolosha AI - Unite.AI
AI Innovations Propel Industry Players To New Heights - Finimize
Evogene and Google Cloud Unveil Foundation Model for Generative Molecule Design, Pioneering a New Era in Life-Science AI - Unite.AI
Top Midday Gainers - MarketScreener
Evogene (EVGN) Stock Nearly Doubles in a Single Day with Explosive 89% Surge - Daily Chhattisgarh News
Evogene’s AI Breakthrough Ignites Stock Surge: What’s Driving the Hype? - RagingBull
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Jane Street Group LLC Acquires Shares of 21,345 Evogene Ltd. (NASDAQ:EVGN) - Defense World
Evogene announces completion of generative AI foundation model with Google Cloud - TipRanks
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PR Newswire
EVGNEvogene Reports First Quarter 2025 Financial Results - mx.advfn.com
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - mx.advfn.com
Evogene price target lowered to $3.50 from $6 at Alliance Global Partners - TipRanks
Evogene Announces Leadership Change and Strategic Shift at Biomica - TipRanks
Evogene (TSE:EVGN) Given a C$1.00 Price Target by Royal Bank of Canada Analysts - Defense World
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery - Barchart.com
Evogene Ltd. Earnings Call: Balancing Growth and Challenges - TipRanks
Evogene Ltd (EVGN) Q1 2025 Earnings Call Highlights: Strategic Expense Reductions and Promising ... - Yahoo Finance
Evogene stock target cut to $3.50, maintains buy at Lake Street - Investing.com Nigeria
Evogene price target lowered to $3.50 from $5 at Lake Street - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Evogene: Q1 Earnings Snapshot - New Haven Register
Evogene Reports First Quarter 2025 Financial Results - Krishak Jagat
Evogene Ltd. Reports Q1 2025 Financial Results - TipRanks
Evogene earnings beat by $0.35, revenue fell short of estimates - Investing.com Australia
Evogene Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 - Investing.com
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 By Investing.com - Investing.com UK
Evogene Announces Q1 2025 Financial Results and Strategic Acquisition - TipRanks
Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene (EVGN) Projected to Post Quarterly Earnings on Wednesday - Defense World
Evogene Schedules First Quarter 2025 Financial Results Release - Krishak Jagat
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - Barchart.com
Evogene Announces Pricing Of US$8,500,000 Registered Direct Offering - Barchart.com
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
0.39%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):